Anti-infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease.
Saved in:
| Title: | Anti-infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease. |
|---|---|
| Authors: | Zitomersky N; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Chi L; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA., Liu E; Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, Massachusetts, USA., Bray KR; Prometheus Laboratories Inc, San Diego, California, USA.; ProciseDx LLC, San Diego, California, USA., Papamichael K; Harvard Medical School, Boston, Massachusetts, USA.; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Cheifetz AS; Harvard Medical School, Boston, Massachusetts, USA.; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Snapper SB; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Bousvaros A; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Silvester JA; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. |
| Source: | Journal of pediatric gastroenterology and nutrition [J Pediatr Gastroenterol Nutr] 2024 Feb; Vol. 78 (2), pp. 261-271. Date of Electronic Publication: 2023 Dec 27. |
| Publication Type: | Observational Study; Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 8211545 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-4801 (Electronic) Linking ISSN: 02772116 NLM ISO Abbreviation: J Pediatr Gastroenterol Nutr Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38374555 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Anti-infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zitomersky+N%22">Zitomersky N</searchLink>; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Chi+L%22">Chi L</searchLink>; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Liu+E%22">Liu E</searchLink>; Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Bray+KR%22">Bray KR</searchLink>; Prometheus Laboratories Inc, San Diego, California, USA.; ProciseDx LLC, San Diego, California, USA.<br /><searchLink fieldCode="AU" term="%22Papamichael+K%22">Papamichael K</searchLink>; Harvard Medical School, Boston, Massachusetts, USA.; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Cheifetz+AS%22">Cheifetz AS</searchLink>; Harvard Medical School, Boston, Massachusetts, USA.; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Snapper+SB%22">Snapper SB</searchLink>; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Bousvaros+A%22">Bousvaros A</searchLink>; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Silvester+JA%22">Silvester JA</searchLink>; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228211545%22">Journal of pediatric gastroenterology and nutrition</searchLink> [J Pediatr Gastroenterol Nutr] 2024 Feb; Vol. 78 (2), pp. 261-271. <i>Date of Electronic Publication: </i>2023 Dec 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Observational Study; Journal Article; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8211545 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1536-4801 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202772116%22">02772116 </searchLink><i>NLM ISO Abbreviation: </i>J Pediatr Gastroenterol Nutr <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38374555 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/jpn3.12074 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 261 Titles: – TitleFull: Anti-infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zitomersky N – PersonEntity: Name: NameFull: Chi L – PersonEntity: Name: NameFull: Liu E – PersonEntity: Name: NameFull: Bray KR – PersonEntity: Name: NameFull: Papamichael K – PersonEntity: Name: NameFull: Cheifetz AS – PersonEntity: Name: NameFull: Snapper SB – PersonEntity: Name: NameFull: Bousvaros A – PersonEntity: Name: NameFull: Silvester JA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2024 Feb Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1536-4801 Numbering: – Type: volume Value: 78 – Type: issue Value: 2 Titles: – TitleFull: Journal of pediatric gastroenterology and nutrition Type: main |
| ResultId | 1 |